About the Journal

Mesothelioma is a type of cancer that occurs in the mesothelium, the protective layer of tissue protecting most internal organs. Pleural mesothelioma, the most common variant, is a malignancy that impacts the tissue encasing the lungs.

Chest pain, dyspnoea, unexplained weight loss, fatigue, and subcutaneous nodules on the chest are symptoms potentially linked to mesothelioma. Additional symptoms encompass lethargy. Various forms and stages of cancer might elicit these symptoms to present in diverse manners.

In several instances, malignancies such as mesothelioma are induced by exposure to asbestos, a fibrous mineral that was often employed in the manufacture of construction materials until recently. Asbestos exposure is predominantly encountered in occupational settings, including building sites, shipyards, and factories. Moreover, asbestos exposure can occur through secondary contact, which happens when an individual interacts with someone employed in asbestos-related activities.

This publication aims to be a crucial reference for medical professionals and researchers engaged in the study and treatment of mesothelioma and other asbestos-related diseases.

No money is required for the processing of articles in this publication.

Announcements

Introducing "Mesothelioma Today": A New Academic Journal Fully Dedicated to Asbestos-Related Diseases

2025-01-10

We are excited to announce the launch of Mesothelioma Today, a new academic journal devoted exclusively to asbestos-related diseases. This journal aims to serve as a comprehensive platform for researchers, clinicians, and policymakers to share their findings, insights, and innovations in the field of mesothelioma and other asbestos-related conditions.
Main objectives of the journal are as follows:
1. Raise Awareness: The primary objective is to raise awareness about asbestos-related diseases, including mesothelioma, asbestosis, and other related conditions.
2. Promote Research: The journal will publish cutting-edge research articles, case studies, and reviews to advance the understanding of asbestos-related diseases and their treatment.
3. Facilitate Collaboration: By providing a dedicated platform for experts in the field, the journal aims to foster collaboration and knowledge-sharing among researchers, clinicians, and industry professionals.
4. Support Policy Development: The journal will also contribute to the development of evidence-based policies and guidelines to improve the prevention, diagnosis, and treatment of asbestos-related diseases.
5. Content and Scope: Mesothelioma Today will feature a wide range of content, including original research articles, review articles, case reports, and editorials. The journal will cover various aspects of asbestos-related diseases, such as epidemiology, pathophysiology, diagnosis, treatment, and prevention. Additionally, the journal will highlight emerging trends and innovations in the field, as well as provide updates on ongoing clinical trials and research projects.

________________________________________________________________________________________________________________________

Call for Submissions: We invite researchers, clinicians, and industry professionals to submit their work to "Mesothelioma Today." We are particularly interested in high-quality, peer-reviewed manuscripts that contribute to the advancement of knowledge and practice in the field of asbestos-related diseases. Submissions can be made through our online submission system, and all manuscripts will undergo rigorous peer review to ensure scientific rigor and relevance.

This new journal is completely Open Access and free of charge: no cost for either submitting or publishing articles.

With the launch of Mesothelioma Today, we aim to create a vibrant and dynamic academic community focused on addressing the challenges posed by asbestosrelated diseases. We believe that through collaboration and innovation, we can make significant strides in improving the lives of those affected by these conditions. Join us in this important endeavor and contribute to the growing body of knowledge in this critical area of research.

Camillo Porta, Editor-in-Chief